Physician profile
Robert Carr
NPI 1720596521
$2,152.78
in general payments reported to CMS, 2019-2025
22 companies · $575 in 2025
The $575 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $370 · 2022: $283 · 2023: $378 · 2024: $546 · 2025: $575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,499.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $611.16 | 2021-2025 | Dupixent, Libtayo |
| Optinose US, INC. | $281.70 | 2021-2025 | |
| Glaxosmithkline, LLC. | $277.58 | 2023-2025 | Nucala |
| Stryker Corporation | $183.26 | 2021-2022 | |
| Acclarent, INC | $121.70 | 2022-2023 | Trudi Nav Cable |
| Hikma Pharmaceuticals USA | $114.34 | 2022-2024 | Ryaltris |
| Intersect Ent, INC. | $90.10 | 2021 | |
| Genzyme Corporation | $85.23 | 2024-2025 | |
| Lucid Diagnostics INC. | $61.75 | 2023 | |
| Novartis Pharmaceuticals Corporation | $50.42 | 2021-2025 | |
| Integra Lifesciences Corporation | $40.33 | 2024 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Astrazeneca Pharmaceuticals Lp | $37.33 | 2021-2025 | |
| Paratek Pharmaceuticals, INC. | $36.18 | 2025 | Xhance |
| Ars Pharmaceuticals Operations, INC. | $28.18 | 2025 | Neffy |
| Circassia INC. | $23.99 | 2024 | Niox |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $21.09 | 2021 | |
| Medtronic, INC. | $18.42 | 2025 | Propel |
| Janssen Pharmaceuticals, INC | $18.26 | 2021 | |
| Amgen INC. | $15.97 | 2025 | Tezspire |
| Kaleo, INC. | $15.06 | 2021 | |
| Alk-Abello, INC | $13.84 | 2021 | |
| Itamar Medical INC | $6.89 | 2025 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.